AstraZeneca PLC is 26.6x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($286.27 B vs $10.74 B). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | BMRN | AZN |
|---|---|---|
| Market cap | $10.74 B | $286.27 B |
| US-listed rank | #903 | #45 |
| Revenue (latest FY) | $3.22B | - |
| Net income (latest FY) | $348.90M | - |
| Net margin | 10.8% | - |
| P/E (trailing FY) | 30.8 | - |
| SEC filings | 2,709 | 1,004 |
AstraZeneca PLC is 26.6x more valuable than BIOMARIN PHARMACEUTICAL INC by market capitalization ($286.27 B vs $10.74 B).
Full pages: BIOMARIN PHARMACEUTICAL INC and AstraZeneca PLC, or browse the full rankings.